MediWound Ltd

MDWDNASDAQ · USD
13.43USD-0.17 (-1.25%)
155

MediWound Ltd (MDWD) Covered Calls

As of October 1, 2026, MDWD has 4 covered call opportunities in the coming three months. Return ranges from 3.7 to 25.6% until expiration. Annualized return ranges from 7.9 to 54.4%. The nearest expiration is December 18, 2026. Maximum potential profit is $357.

Read more

Running MDWD covered calls helps you generate consistent income from MediWound Ltd's shares you already own, turning a long stock position into a yield-producing asset. A covered call on MediWound Ltd involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best MDWD covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if MDWD stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling MDWD covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given MediWound Ltd covered call is worth writing.

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd.

was founded in 2000 and is headquartered in Yavne, Israel.

Income-focused investors, long-term MDWD holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling MDWD covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best MediWound Ltd covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile19.44% Subdued
  • Market cap (M$)176
  • 52 weeks high-32.10%
  • 52 weeks low8.63%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$30.67
    128.37% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-19
  • P/E—
  • Future P/E—
  • EPS (ttm)-1.60
  • EPS growth next 5 years16.86%

As of October 1, 2026

2027-03-1917217.0022.040.501.00357.0025.6354.39-3.59+0.3240.50
2026-12-188115.007.680.251.30132.009.4842.70-1.79+0.42351.05
2027-03-1917215.007.680.751.90182.0013.0727.73-5.38+0.4901.15
2027-03-1917214.000.500.453.8052.003.737.92-3.23+0.5923.35

As of October 1, 2026

Sell covered calls with the data behind you

Find the best MDWD covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial